Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus

Gariani, Karim; Marques-Vidal, Pedro; Waeber, Gérard; Vollenweider, Peter; Jornayvaz, François

doi:10.1530/EC-19-0251

Scientific article

English

Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus

ContributorsGariani, Karim; Marques-Vidal, Pedro; Waeber, Gérard; Vollenweider, Peter; Jornayvaz, François

Published inEndocrine Connections, vol. 8, no. 7, p. 870-877

Publication date2019

Abstract

Excessive glucocorticoid secretion has been associated with type 2 diabetes mellitus (T2DM) and other features of the metabolic syndrome. We aimed to evaluate if basal salivary cortisol may predict occurrence of new insulin resistance (IR) or T2DM.

Keywords

Salivary cortisol
Insulin resistance
Diabetes
Prospective study
Epidemiology

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Funding

Citation (ISO format)

GARIANI, Karim et al. Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus. In: Endocrine Connections, 2019, vol. 8, n° 7, p. 870–877. doi: 10.1530/EC-19-0251

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:130217
DOI : 10.1530/EC-19-0251
PMID : 31176299

Additional URL for this publicationhttps://ec.bioscientifica.com/view/journals/ec/8/7/EC-19-0251.xml

Journal ISSN2049-3614

281views

92downloads

Creation22/01/2020 08:02:00

First validation22/01/2020 08:02:00

Update time17/01/2025 16:43:25

Status update17/01/2025 16:43:25

Last indexation17/01/2025 17:00:43

Archive ouverte UNIGE

Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus

Excessive glucocorticoid secretion has been associated with type 2 diabetes mellitus (T2DM) and other features of the metabolic syndrome. We aimed to evaluate if basal salivary cortisol may predict occurrence of new insulin resistance (IR) or T2DM.

Technical informations